Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?
作者： Z.A. Massy , W.F. Keane , B.L. Kasiske
DOI: 10.1016/S0140-6736(96)90217-2
关键词:
摘要: … of mevalonate pathway products other than cholesterol, and … distinguish effects due to altered cholesterol from those due to … plasma concentrations of cholesterol, but also of mevalonate, …
elsevier.com
sci-hub.se 参考文章(18)
Pappu As, Illingworth Dr, Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia. Journal of Laboratory and Clinical Medicine. ,vol. 114, pp. 554- 562 ,(1989)
T Chojnacki, G Dallner, The biological role of dolichol. Biochemical Journal. ,vol. 251, pp. 1- 9 ,(1988) , 10.1042/BJ2510001
Catovsky D, Clutterbuck Rd, Powles Rl, Newman A, DeLord C, Millar Jl, The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. Journal of Investigative Medicine. ,vol. 43, pp. 269- ,(1995)
Donald B. Hunninghake, HMG CoA reductase inhibitors Current Opinion in Lipidology. ,vol. 3, pp. 22- 28 ,(1992) , 10.1097/00041433-199202000-00005
S Vickers, R A Halpin, I W Chen, D E Duggan, M S Schwartz, C A Duncan, W F Bayne, R J Stubbs, The physiological disposition of lovastatin. Drug Metabolism and Disposition. ,vol. 17, pp. 166- 173 ,(1989)
M P O'Donnell, B L Kasiske, Y Kim, D Atluru, W F Keane, Lovastatin Inhibits Proliferation of Rat Mesangial Cells Journal of Clinical Investigation. ,vol. 91, pp. 83- 87 ,(1993) , 10.1172/JCI116204
Henry Y. Pan, Arthur R. DeVault, David Wang-Iverson, Eugene Ivashkiv, Brian N. Swanson, A. Arthur Sugerman, Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin The Journal of Clinical Pharmacology. ,vol. 30, pp. 1128- 1135 ,(1990) , 10.1002/J.1552-4604.1990.TB01856.X
Antonio M. Gotto, Lipid Lowering, Regression, and Coronary Events A Review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council Meeting Circulation. ,vol. 92, pp. 646- 656 ,(1995) , 10.1161/01.CIR.92.3.646
A. Corsini, M. Raiteri, M. Soma, R. Fumagalli, R. Paoletti, Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes. Pharmacological Research. ,vol. 23, pp. 173- 180 ,(1991) , 10.1016/S1043-6618(05)80119-7
M R Soma, E Donetti, C Parolini, G Mazzini, C Ferrari, R Fumagalli, R Paoletti, HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 13, pp. 571- 578 ,(1993) , 10.1161/01.ATV.13.4.571